Although point mutations have been commonly described, DNA copy number variations (CNVs) have been reported as an alternative mechanism for cancer predisposition for at least 30% of known Mendelian cancer genes [5,6], including TP53[7,8], APC[9], BRCA1[10] and the mismatch repair gene MSH2[9]. This evidence concerns the gene TP53 and cancer.